Here are the 10-Q quarterly reports from Averin Capital Acquisition Corp. (ACAA) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow ACAA and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ACAA filings page.
Averin Capital Acquisition Corp. (ACAA) reported net income of $2,049,481 for the three months ended September 30, 2026: $2,618,691 of interest income from cash and Trust Account investments offset $569,210 of formation, general and administrative costs. For the nine months, net income was $5,237,537, including $6,125,781 in trust interest. The company had no operating revenue and said its activities focused on evaluating acquisition candidates; it had no definitive agreement with a specific target as of September 30, 2026.
At September 30, 2026, the company held $289,485,861 in Trust Account investments and $479,839 in cash outside the account; net cash used in operating activities for the nine months was $819,918. Management said it lacked liquidity to sustain operations for at least one year, raising substantial doubt about its ability to continue as a going concern. The company has until February 20, 2028 to complete a business combination, or May 20, 2028 if it has a definitive agreement by February 20, 2028. It intends to use substantially all Trust Account funds for a business combination.
On October 16, 2026, independent director Mary Szela resigned from the board and two committees. Graeme Bell became compensation committee chair, and Akiko Moni Miyashita joined the audit committee.
Averin Capital Acquisition Corp., a Cayman Islands blank check company, reported net income of $3,188,056 for the six months ended June 30, 2026, driven almost entirely by $3,507,090 of interest on funds invested in its SPAC trust account, with minimal operating activity.
The company has $287,367,170 in a regulated Trust Account, largely representing 28,386,008 Class A Ordinary Shares subject to possible redemption at $10.12 per share. Outside the Trust, cash available for expenses was only $339,276 and working capital was $338,659 as of June 30, 2026.
Management states there is substantial doubt about the company’s ability to continue as a going concern, given limited liquidity and ongoing acquisition-related costs. The SPAC must complete a Business Combination by February 20, 2028 (or May 20, 2028 if a definitive agreement is in place by February 20, 2028) or redeem all public shares and liquidate.
Averin Capital Acquisition Corp., a SPAC focused on technology and health, reported net income of $832,500 for the three months ended March 31, 2026, mainly from $987,118 of interest on funds in its trust account. Total assets were $285.5M, including $284.8M of investments in the Trust Account backing 28,386,008 Class A shares subject to redemption at about $10.03 per share. The SPAC raised $283.9M through its IPO, over-allotment and private placement, and has a deferred underwriting fee of $15.6M payable upon completing a business combination. Management discloses substantial doubt about the company’s ability to continue as a going concern due to limited working capital and the requirement to complete a business combination by February 20, 2028 (or May 20, 2028 with a signed deal) or liquidate.